Diabetes Case Reports

Department of Internal Medicine, Fujiidera Municipal Hospital, Fujiidera, Japan

Publications

• Research Article   
  The Effect of Oral Semaglutide on Urinary Albumin to Creatinine Ratio in Patients with Type 2 Diabetes
  Author(s): Masahiro Yano*, Sadahiko Uchimoto, Masami Nishimura and Saori Yamaguchi
  
  Background: Oral semaglutide has been shown to have excellent effects such as reduction of HbA1c and weight loss. However, there are no reports of the effect of oral semaglutide on Urinary Albumin to Creatinine Ratio (UACR). In this study, we investigated the effect of oral semaglutide on UACR in patients with type 2 diabetes who switched from Dipeptidyl Peptidase-4 (DPP4) inhibitors to oral semaglutide. Method: Thirty patients with type 2 diabetes (15 males, 15 females, average age 60.3 years old), whose UACR was measured before and after switching from DPP4 inhibitors to oral semaglutide, were investigated. It was compared between before and after 6.6 months on averages that body weight, systolic and diastolic blood pressure, HbA1c, Low-Density Lipoprotein Cholesterol (LDL-C), and UACR. Result: Afte.. View more»
  

  DOI: 10.35248/2572-5629.23.8.168.

  Abstract HTML PDF